Cite
APA Citation
Gamba, S., Camaj, P., Heinemann, V., Laubender, R. P., Wang, Y., Zhao, Y., Stintzing, S., Giessen, C., Boeck, S., Haertl, C., Bruns, C. J., & Modest, D. P. (2015). effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Anti-cancer drugs, 26(4), . http://access.bl.uk/ark:/81055/vdc_100052627674.0x000007